MOZ is critical for the development of MOZ/MLL fusion-induced leukemia through regulation of Hoxa9/Meis1 expression.

Katsumoto, Takuo; Ogawara, Yoko; Yamagata, Kazutsune; Aikawa, Yukiko; Goitsuka, Ryo; Nakamura, Takuro; Kitabayashi, Issay

Katsumoto, Takuo; Ogawara, Yoko; Yamagata, Kazutsune; Aikawa, Yukiko; Goitsuka, Ryo; Nakamura, Takuro; Kitabayashi, Issay.

Afiliação

Katsumoto T; Division of Hematological Malignancy, National Cancer Center Research Institute, Tokyo, Japan.
Ogawara Y; Division of Hematological Malignancy, National Cancer Center Research Institute, Tokyo, Japan.
Yamagata K; Division of Hematological Malignancy, National Cancer Center Research Institute, Tokyo, Japan.
Aikawa Y; Division of Hematological Malignancy, National Cancer Center Research Institute, Tokyo, Japan.
Goitsuka R; Division of Development and Aging, Research Institute for Biomedical Sciences, Tokyo University of Science, Chiba, Japan.
Nakamura T; Division of Carcinogenesis, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
Kitabayashi I; Department of Experimental Pathology, Institute of Medical Science, Tokyo Medical University, Tokyo, Japan.

Blood Adv ; 6(19): 5527-5537, 2022 10 11.

Article em En | MEDLINE | ID: mdl-35947126

Assuntos

Leucemia Mieloide Aguda; Animais; Cromatina; Hematopoese; Histona Acetiltransferases/genética; Leucemia Mieloide Aguda/genética; Leucemia Mieloide Aguda/metabolismo; Metilcelulose; Camundongos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda Limite: Animals Idioma: En Revista: Blood Adv Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google